![](/img/cover-not-exists.png)
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer
Vaklavas, Christos, Roberts, Brian S., Varley, Katherine E., Lin, Nancy U., Liu, Minetta C., Rugo, Hope S., Puhalla, Shannon, Nanda, Rita, Storniolo, Anna Maria, Carey, Lisa A., Saleh, Mansoor N., Li,Volume:
22
Language:
english
Journal:
Breast Cancer Research
DOI:
10.1186/s13058-020-01258-x
Date:
December, 2020
File:
PDF, 1.20 MB
english, 2020